TP53 and breast carcinoma: We treated 9 breast cancer cell lines endogenously expressing a mutant p53 (MDA-MB-468, HCC-1954, MDA-MB-231, AU-565, SKBR-3, HCC-202, BT-474, HCC1419, and T47D) with various concentrations of paclitaxel in vitro.